skip over navigation

Patient Care

Dotted Line Find a Physician Dotted Line Physicians by Last Name
Dotted Line Print on Demand Directory Dotted Line

More Information

Dotted Line

Please call 1-866-645-6455 or 214-645-6455 to learn more information about any of our physicians.

David Miller, MD

David Miller, MD

Professor

Recent Publications Miller, D.S., Blessing, J.A., Bodurka, D.C., Bonebrake, A.J., Schorge, J.O. , "Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group " Gynecologic Oncology , 110(1): 65-70 , July 2008

Bull Phelps, S.L., Schorge, J.O., Peyton, M.J., Shigematsu, H., Xiang, L.-L., Miller, D.S., Lea, J.S. , "Implications of EGFR inhibition in ovarian cancer cell proliferation " Gynecologic Oncology , 109(3): 411-7 , June 2008

Bull-Phelps, S.L., Garner, E.I.O., Walsh, C.S., Gehrig, P.A., Miller, D.S., Schorge, J.O. , "Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix " Gynecologic Oncology , 107 (2): 316-319 , November 2007

Knowles, L.M., Drake, R.D., Ashfaq, R., Castrillon, D.H., Miller, D.S., Schorge, J.O. , "Simplifying the preevacuation testing strategy for patients with molar pregnancy " The Journal of reproductive medicine , 52 (8): 685-688 , August 2007

Lea, J.S., Sunaga, N., Sato, M., Kalahasti, G., Miller, D.S., Minna, J.D., Muller, C.Y. , "Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells " Reproductive Sciences , 14 (1): 20-28 , 2007

Significant Publications
O’Boyle, J.D., Coleman, R.L., Bernstein, S.G., Lifshitz, S., Muller, C.Y., Miller, D.S. , "Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study " Gynecologic Oncology , 79 (2): 238-243 , 2000

Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM. , "Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers " Human Molecular Genetics , 7 (2): 195-202 , 1998

Moore DH. Blessing JA. McQuellon RP. Thaler HT. Cella D. Benda J. Miller DS. Olt G. King S. Boggess JF. Rocereto TF. , "Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study " Journal of Clinical Oncology , 22(15): 3113-9 , August 2004

Long HJ 3rd. Bundy BN. Grendys EC Jr. Benda JA. McMeekin DS. Sorosky J. Miller DS. Eaton LA. Fiorica JV. , "Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study " Journal of Clinical Oncology , 23(21): 4626-33 , July 2005

Bulun, S.E., Economos, K., Miller, D., Simpson, E.R. , "CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors " Journal of Clinical Endocrinology and Metabolism , 79 (6): 1831-1834 , 1994

Drop Shadow